Recombinant Mycobacterium tuberculosis Uncharacterized protein Rv0647c (Rv0647c)

Shipped with Ice Packs
In Stock

Description

Gene Location and Annotations

  • Locus: Rv0647c (Chromosome position: 741,151–742,617 bp, reverse strand)

  • Length: 488 amino acids

  • Functional Category: Conserved hypothetical protein with unknown enzymatic activity .

  • Homology: Shares similarity with ABC1-like proteins in Mycobacterium leprae (NP_302277.1) and Synechocystis (P73627) .

Domains and Post-Translational Modifications

  • Contains a conserved ABC1 domain, suggesting potential involvement in protein kinase activity or ATP binding .

  • Phosphorylation sites predicted in proteomic studies .

Subcellular Distribution

  • Identified in membrane, cytosol, and cell wall fractions via proteomic profiling :

CompartmentDetection MethodStudy
Membrane1D-SDS-PAGE, nanoLC-MS/MSGu et al., 2003
Cell Wall2DLC/MSMawuenyega et al., 2005
CytosolTriton X-114 extractionMalen et al., 2010

Essentiality in Growth

  • Conflicting mutagenesis data:

    • Essential: Critical for growth in cholesterol-rich media (Griffin et al., 2011) and MtbYM medium (Minato et al., 2019) .

    • Non-essential: Reported in standard H37Rv cultures (Sassetti et al., 2003) .

Expression Systems

  • Hosts: E. coli, yeast, baculovirus, and mammalian cells .

  • Purity: >85% (SDS-PAGE) with Tris/PBS-based buffer and trehalose stabilizers .

Sequence and Stability

  • Amino Acid Sequence: Begins with MRAEIGPDFR... (full sequence available in UniProt P9WQI0) .

  • Storage: Lyophilized form stable for 12 months at -20°C/-80°C .

Research Applications

  • Vaccine Development: Investigated as a subunit vaccine candidate due to surface localization in M. tuberculosis .

  • Host-Pathogen Interaction Studies: Membrane association suggests potential roles in cell envelope integrity or signaling .

Predicted Functional Partners

STRING database analysis reveals interactions with proteins involved in lipid metabolism and cell wall synthesis :

Partner GeneFunctionInteraction Score
lipG (Rv0646c)Lipase/esterase activity0.996
mmaA1Mycolic acid methylation0.881
Rv0648Alpha-mannosidase0.586

Key Research Gaps and Future Directions

  • Functional Characterization: No direct enzymatic activity confirmed despite homology to ABC1-like kinases .

  • Role in Virulence: Essentiality in cholesterol metabolism implies relevance in persistent infections .

  • Immunogenicity: Untested in animal models, despite recombinant availability .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery time varies based on purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, contact us in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C. The lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receiving. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag type, please inform us, and we will prioritize its development.
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-488
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Mycobacterium tuberculosis
Target Names
Rv0647c
Target Protein Sequence
MRAEIGPDFR PHYTFGDAYP ASERAHVNWE LSAPVWHTAQ MGSTTHREVA KLDRVPLPVE AARVAATGWQ VTRTAVRFIG RLPRKGPWQQ KVIKELPQTF ADLGPTYVKF GQIIASSPGA FGESLSREFR GLLDRVPPAK TDEVHKLFVE ELGDEPARLF ASFEEEPFAS ASIAQVHYAT LRSGEEVVVK IQRPGIRRRV AADLQILKRF AQTVELAKLG RRLSAQDVVA DFADNLAEEL DFRLEAQSME AWVSHLHASP LGKNIRVPQV HWDFTTERVL TMERVHGIRI DNAAAIRKAG FDGVELVKAL LFSVFEGGLR HGLFHGDLHA GNLYVDEAGR IVFFDFGIMG RIDPRTRWLL RELVYALLVK KDHAAAGKIV VLMGAVGTMK PETQAAKDLE RFATPLTMQS LGDMSYADIG RQLSALADAY DVKLPRELVL IGKQFLYVER YMKLLAPRWQ MMSDPQLTGY FANFMVEVSR EHQSDIEV
Uniprot No.

Q&A

What is Mycobacterium tuberculosis protein Rv0647c?

Rv0647c (also known as MT0675) is an uncharacterized protein from Mycobacterium tuberculosis, the causative agent of tuberculosis . As an uncharacterized protein, its precise function, structure, and role in M. tuberculosis biology have not been fully determined. Current research approaches typically combine bioinformatics analysis, structural characterization, and functional assays to elucidate the biological significance of such proteins within the context of M. tuberculosis pathogenesis.

What expression systems are suitable for producing recombinant Rv0647c protein?

According to available data, recombinant Rv0647c (aa 1-488) can be expressed in several heterologous systems including E. coli, yeast, baculovirus, and mammalian cell cultures . The selection of an expression system should be guided by research objectives:

  • E. coli systems offer high yield and cost-effectiveness but may lack post-translational modifications

  • Yeast provides eukaryotic processing capabilities with moderate yield

  • Baculovirus expression is advantageous for larger proteins requiring specific folding environments

  • Mammalian cell systems deliver the most authentic post-translational modifications

For initial characterization studies, E. coli expression is typically attempted first due to its simplicity and scalability, before progressing to more complex systems if functionality issues arise.

How does the study of Rv0647c relate to other characterized proteins in Mycobacterium tuberculosis?

While the search results don't provide specific information about Rv0647c's relationships to other proteins, researchers investigating uncharacterized mycobacterial proteins typically examine genomic context and potential functional relationships. M. tuberculosis contains several well-studied gene clusters involved in cell wall biosynthesis, such as the mmaA1-mmaA2-mmaA3-mmaA4 genes that participate in mycolic acid modifications . Understanding the proximity of Rv0647c to these clusters and analyzing sequence homology patterns may provide insights into its potential functional associations.

What are the recommended experimental design approaches for characterizing the function of Rv0647c?

When designing experiments to characterize uncharacterized proteins like Rv0647c, researchers should follow structured experimental design principles addressing the five key areas of difficulty identified in research design literature :

  • Define experimental subject properties - clearly characterize the recombinant protein and expression system

  • Establish manipulated variables - determine which conditions or treatments will be systematically altered

  • Identify appropriate measurement outcomes - select assays that can detect potential functions

  • Account for variability - implement proper controls and replication

  • Consider the scope of inference - understand the limitations of experimental findings

A systematic experimental approach should include:

  • Bioinformatic prediction of potential functions

  • Gene knockout or knockdown studies

  • Protein localization determination

  • Interaction partner identification

  • Structural analysis through crystallography or cryo-EM

How can researchers validate experimental designs when studying Rv0647c?

Experimental design validation when studying uncharacterized proteins like Rv0647c requires rigorous assessment across multiple criteria. According to experimental design rubrics , researchers should ensure:

These validation steps help researchers avoid common pitfalls in experimental design that have persisted in biological research for decades .

What bioinformatic approaches can predict potential functional domains and activities of Rv0647c?

For uncharacterized proteins like Rv0647c, comprehensive bioinformatic analysis forms the foundation for functional hypothesis generation. A multi-layered approach should include:

Analysis TypeMethodsExpected Outcomes
Sequence-based analysisBLAST searches, Multiple sequence alignment, HMM profile searchesIdentification of homologous proteins, conserved domains, functional motifs
Structural predictionSecondary structure prediction, Homology modeling, AlphaFold2 predictionPotential structural features, active sites, binding pockets
Genomic context analysisGene neighborhood analysis, Operon predictionFunctional associations, metabolic pathway connections
Evolutionary analysisPhylogenetic profiling, Selective pressure analysis (dN/dS ratios)Evolutionary conservation, potential essential functions

Integration of these computational approaches generates testable hypotheses about Rv0647c function that can guide subsequent experimental validation strategies.

How can researchers design experiments to determine if Rv0647c is involved in mycolic acid biosynthesis or cell wall formation?

Given the critical importance of mycolic acids in M. tuberculosis pathogenesis , investigating whether Rv0647c plays a role in cell wall biosynthesis requires a systematic experimental approach:

  • Generate genetic manipulation strains:

    • Create precise Rv0647c knockout mutants

    • Develop complemented strains expressing wild-type Rv0647c

  • Perform comprehensive lipid profiling:

    • Extract mycolic acids using established protocols

    • Analyze using thin-layer chromatography (TLC) as described for other mycolic acid studies

    • Compare profiles between wild-type and Rv0647c mutant strains

    • Quantify potential changes in mycolic acid subtypes (α-MA, keto-MA, methoxy-MA)

  • Assess cell wall integrity:

    • Examine cell envelope structure through electron microscopy

    • Test susceptibility to cell wall-targeting antibiotics

    • Conduct permeability assays with hydrophobic compounds

  • Investigate potential interactions with known cell wall biosynthesis proteins:

    • Test for interactions with proteins in the mmaA gene cluster, which includes mmaA1-mmaA2-mmaA3-mmaA4

    • Examine relationships to the hadA-hadB-hadC genes of the fatty acid synthase II (FAS II) operon

These experimental approaches would generate comprehensive evidence regarding any potential role of Rv0647c in mycolic acid biosynthesis or broader cell wall formation.

What are the challenges and solutions in purifying recombinant Rv0647c for structural studies?

Purifying mycobacterial proteins for structural studies presents specific challenges that require methodological solutions:

ChallengeSolution ApproachMethodological Details
Potential insolubilityExpression tag optimizationTest multiple solubility tags (His, MBP, GST, SUMO); Evaluate expression at lower temperatures (16-20°C)
Proper foldingSpecialized expression strainsUse strains with chaperone co-expression; Consider mycobacterial expression systems
Protein stabilityBuffer optimizationScreen stabilizing additives; Implement thermal shift assays to identify optimal conditions
Yield limitationsExpression system selectionCompare yields across expression systems mentioned in search result (E. coli, yeast, baculovirus, mammalian)
Purification challengesMulti-step purification strategyImplement sequential chromatography (affinity, ion exchange, size exclusion); Verify protein homogeneity

These methodological considerations are essential for obtaining purified Rv0647c suitable for downstream structural biology applications such as X-ray crystallography or cryo-electron microscopy.

How can proteomics approaches be used to identify potential interaction partners of Rv0647c?

Understanding the protein interaction network of uncharacterized proteins like Rv0647c provides crucial functional insights. Researchers should implement a multi-faceted proteomics strategy:

  • Affinity-based methods:

    • Express epitope-tagged Rv0647c in mycobacterial cells

    • Perform co-immunoprecipitation followed by mass spectrometry

    • Use crosslinking agents to capture transient interactions

    • Implement proximity-dependent labeling technologies (BioID, APEX)

  • Validation techniques:

    • Bacterial two-hybrid screening

    • Direct binding assays (surface plasmon resonance, isothermal titration calorimetry)

    • Co-localization studies with fluorescently tagged proteins

  • Bioinformatic integration:

    • Incorporate protein co-expression data

    • Analyze genomic context alongside proteomics results

    • Predict functional associations through network analysis

This comprehensive approach helps establish the interaction landscape of Rv0647c, potentially revealing its functional role within M. tuberculosis biology.

How might genetic variations in Rv0647c across M. tuberculosis lineages impact research findings?

When studying mycobacterial proteins, researchers must consider genetic diversity across M. tuberculosis lineages. As demonstrated with other M. tuberculosis genes like mmaA3 (Rv0643c), lineage-specific mutations can significantly impact protein function . For Rv0647c research:

  • Perform comparative genomic analysis:

    • Analyze Rv0647c sequences across diverse clinical isolates and reference strains

    • Identify single nucleotide polymorphisms (SNPs) or other genetic variations

    • Determine if variations are conserved within specific lineages

    • Assess whether variations impact protein structure or function using predictive tools

  • Consider experimental implications:

    • Include multiple strain backgrounds in functional studies

    • Test complementation with variant alleles

    • Evaluate phenotypic differences across lineages

This approach ensures research findings about Rv0647c are appropriately contextualized within M. tuberculosis diversity and evolution, similar to studies of mmaA3 gene variants that revealed lineage-specific functional differences .

What methodological considerations are important for using Rv0647c in diagnostic or vaccine development research?

For academic researchers investigating the potential of Rv0647c as a diagnostic or vaccine candidate, several methodological considerations are critical:

  • Antigenicity assessment:

    • Analyze sequence conservation across clinical isolates

    • Identify potential B-cell and T-cell epitopes through computational prediction

    • Test immunogenicity in appropriate animal models

  • Specificity determination:

    • Perform comparative genomics against non-tuberculous mycobacteria

    • Assess cross-reactivity with human proteins

    • Evaluate specificity in diverse clinical sample testing

  • Accessibility validation for diagnostics:

    • Determine cellular localization of Rv0647c

    • Assess expression levels during different growth phases and in various infection models

    • Evaluate presence in patient samples (sputum, blood, urine)

  • Immunological characterization for vaccine research:

    • Map T-cell and B-cell epitopes experimentally

    • Assess protective immunity in appropriate animal models

    • Evaluate safety through comprehensive immunopathology studies

These methodological considerations provide a scientific framework for evaluating the diagnostic and vaccine potential of Rv0647c, focusing on the research methodology rather than commercial applications.

How can researchers design controlled experiments to determine if Rv0647c plays a role in M. tuberculosis virulence?

Investigating potential virulence contributions of uncharacterized proteins like Rv0647c requires carefully controlled experimental designs that address the five key areas of experimental design difficulty :

  • Generate appropriate genetic manipulation strains:

    • Create precise Rv0647c knockout mutants using specialized mycobacterial genetic tools

    • Develop complemented strains expressing wild-type Rv0647c

    • Create point mutation variants for structure-function analysis

  • Implement a multi-level virulence assessment approach:

    • In vitro cellular models: Macrophage infection assays (survival, replication)

    • Ex vivo tissue models: Granuloma-like structures

    • In vivo infection models: Mouse infection studies with bacterial burden and histopathology assessment

  • Apply comprehensive readouts:

    • Bacterial survival and replication metrics

    • Immune response parameters (cytokine profiles, cell recruitment)

    • Tissue damage and pathology scoring

  • Account for variability through:

    • Appropriate sample sizes based on power calculations

    • Multiple biological and technical replicates

    • Controls for genetic background effects

This systematic approach allows researchers to establish whether Rv0647c contributes to virulence and to characterize the mechanisms involved while adhering to sound experimental design principles .

What approaches can resolve contradictory data when studying Rv0647c function?

When investigating uncharacterized proteins like Rv0647c, researchers often encounter contradictory results across different experimental systems or approaches. Methodological strategies to resolve such contradictions include:

  • Systematic validation across multiple experimental systems:

    • Compare results across different expression systems listed in search result

    • Test function in both in vitro biochemical assays and cellular systems

    • Validate in multiple strain backgrounds

  • Control for experimental variables that might cause contradictions:

    • Protein expression levels and localization

    • Growth conditions and physiological state

    • Genetic background effects

  • Implement orthogonal experimental approaches:

    • Combine genetic, biochemical, and structural methods

    • Use both gain-of-function and loss-of-function approaches

    • Employ both in vitro and in vivo systems

  • Apply the experimental design rubric to identify potential methodological issues :

    • Review variable properties consideration

    • Examine measurement approaches

    • Reassess variability management

This methodological framework helps researchers resolve apparent contradictions and develop a coherent understanding of Rv0647c function.

What specialized research tools and resources are available for studying Rv0647c?

Researchers investigating Rv0647c can access various specialized tools and resources:

Resource CategoryAvailable ToolsApplication to Rv0647c Research
Genetic toolsMycobacterial specialized vectors, CRISPR-Cas9 systemsGeneration of knockout, knockdown, or overexpression strains
Expression systemsE. coli, yeast, baculovirus, mammalian Production of recombinant protein for functional and structural studies
Structural biologyX-ray crystallography, Cryo-EM, NMRDetermination of protein structure and identification of functional domains
Bioinformatic resourcesMycobrowser, TB Database, UniProtAccess to genomic context, conservation, and preliminary annotations
Metabolic analysisTLC protocols for mycolic acid analysis Investigation of potential role in cell wall biosynthesis
Mycobacterial culture systemsSpecialized media formulations (7H9, 7H10, 7H11) Cultivation of M. tuberculosis strains for functional studies

These resources provide researchers with the specialized tools needed to comprehensively study this uncharacterized protein and place findings within the broader context of M. tuberculosis biology.

What are the current limitations in Rv0647c research and how might they be addressed methodologically?

Current limitations in studying uncharacterized mycobacterial proteins like Rv0647c include:

  • Functional annotation challenges:

    • Methodological solution: Implement comprehensive bioinformatic pipelines combining sequence, structure, and genomic context analysis

    • Apply high-throughput phenotypic screening approaches across diverse conditions

  • Difficulty in establishing essentiality:

    • Methodological solution: Use conditional knockdown systems rather than direct knockout

    • Implement CRISPRi approaches with inducible repression

  • Challenges in structural characterization:

    • Methodological solution: Utilize hybrid approaches combining crystallography, cryo-EM, and computational modeling

    • Express protein domains separately if full-length protein proves recalcitrant

  • Limited understanding of in vivo relevance:

    • Methodological solution: Develop more physiologically relevant infection models

    • Implement tissue-specific expression analysis during various infection stages

  • Experimental design limitations:

    • Methodological solution: Apply validated experimental design rubrics to ensure rigorous experimental setup

    • Incorporate multiple measurement approaches to triangulate findings

These methodological approaches help researchers overcome current limitations and advance understanding of Rv0647c's function in M. tuberculosis biology.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.